miR-150-PTPMT1-cardiolipin signaling in pulmonary arterial hypertension
Open Access
- 4 November 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy Nucleic Acids
- Vol. 23, 142-153
- https://doi.org/10.1016/j.omtn.2020.10.042
Abstract
No abstract availableFunding Information
- British Heart Foundation (PG/16/4/31849)
- Imperial College London
- Saudi Arabia Cultural Bureau in London
This publication has 44 references indexed in Scilit:
- Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2019
- Discerning functional hierarchies of microRNAs in pulmonary hypertensionJCI Insight, 2017
- MicroRNA-150 Inhibits the Activation of Cardiac Fibroblasts by Regulating c-MybCellular Physiology and Biochemistry, 2016
- Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary HypertensionPLOS ONE, 2016
- Advances and Challenges of Liposome Assisted Drug DeliveryFrontiers in Pharmacology, 2015
- Cellular microRNAs up-regulate transcription via interaction with promoter TATA-box motifsRNA, 2014
- Delivery of Therapeutic siRNA to the Lung Endothelium via Novel Lipoplex Formulation DACCMolecular Therapy, 2014
- Activation of hepatic stellate cells is suppressed by microRNA-150International Journal of Molecular Medicine, 2013
- Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAsNature, 2012
- Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesisNature, 2010